GB Sciences Files Patent Application for Chronic Pain and Heart Therapies

LAS VEGAS, May 23, 2017, GBLX, /PRNewswire/  GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of its latest patent application by its wholly-owned subsidiary, Growblox Life Sciences, LLC for the treatment of chronic pain and heart therapies based on myrcene-containing complex mixtures ( MCCM ). The current US opioid epidemic, along with growing public and government concern regarding opioid abuse, makes new pain treatments a promising field of research and development. Our novel pain formulations are also substantially free of
http://bit.ly/2qT1XTT